343 related articles for article (PubMed ID: 19221377)
1. Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial.
Digenio AG; Mancuso JP; Gerber RA; Dvorak RV
Ann Intern Med; 2009 Feb; 150(4):255-62. PubMed ID: 19221377
[TBL] [Abstract][Full Text] [Related]
2. Effects of sibutramine treatment in obese adolescents: a randomized trial.
Berkowitz RI; Fujioka K; Daniels SR; Hoppin AG; Owen S; Perry AC; Sothern MS; Renz CL; Pirner MA; Walch JK; Jasinsky O; Hewkin AC; Blakesley VA;
Ann Intern Med; 2006 Jul; 145(2):81-90. PubMed ID: 16847290
[TBL] [Abstract][Full Text] [Related]
3. Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial.
Wadden TA; Berkowitz RI; Sarwer DB; Prus-Wisniewski R; Steinberg C
Arch Intern Med; 2001 Jan; 161(2):218-27. PubMed ID: 11176735
[TBL] [Abstract][Full Text] [Related]
4. Long-term weight loss with sibutramine: a randomized controlled trial.
Wirth A; Krause J
JAMA; 2001 Sep; 286(11):1331-9. PubMed ID: 11560538
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of lifestyle modification and pharmacotherapy for obesity.
Wadden TA; Berkowitz RI; Womble LG; Sarwer DB; Phelan S; Cato RK; Hesson LA; Osei SY; Kaplan R; Stunkard AJ
N Engl J Med; 2005 Nov; 353(20):2111-20. PubMed ID: 16291981
[TBL] [Abstract][Full Text] [Related]
6. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
[TBL] [Abstract][Full Text] [Related]
7. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial.
Berkowitz RI; Wadden TA; Tershakovec AM; Cronquist JL
JAMA; 2003 Apr; 289(14):1805-12. PubMed ID: 12684359
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
9. Use of sibutramine to assist obese women with weight loss can be successful in dietitian-led clinics: another tool in the dietitian's toolbox.
Barratt R; Frost G; O'Boyle A; Millward J; Truby H
J Hum Nutr Diet; 2008 Jun; 21(3):248-55. PubMed ID: 18477180
[TBL] [Abstract][Full Text] [Related]
10. Impact of weight loss on the metabolic syndrome.
Phelan S; Wadden TA; Berkowitz RI; Sarwer DB; Womble LG; Cato RK; Rothman R
Int J Obes (Lond); 2007 Sep; 31(9):1442-8. PubMed ID: 17356528
[TBL] [Abstract][Full Text] [Related]
11. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
[TBL] [Abstract][Full Text] [Related]
12. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
[TBL] [Abstract][Full Text] [Related]
13. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
[TBL] [Abstract][Full Text] [Related]
14. Weight loss in obese African American and Caucasian adolescents: secondary analysis of a randomized clinical trial of behavioral therapy plus sibutramine.
Budd GM; Hayman LL; Crump E; Pollydore C; Hawley KD; Cronquist JL; Berkowitz RI
J Cardiovasc Nurs; 2007; 22(4):288-96. PubMed ID: 17589281
[TBL] [Abstract][Full Text] [Related]
15. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
Mathus-Vliegen EM;
Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
[TBL] [Abstract][Full Text] [Related]
16. The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) study: evaluating the role of drug therapy within a weight management program in a group-model health maintenance organization.
Porter JA; Raebel MA; Conner DA; Lanty FA; Vogel EA; Gay EC; Merenich JA
Am J Manag Care; 2004 Jun; 10(6):369-76. PubMed ID: 15209480
[TBL] [Abstract][Full Text] [Related]
17. Weight loss in obese Mexican Americans treated for 1-year with orlistat and lifestyle modification.
Poston WS; Reeves RS; Haddock CK; Stormer S; Balasubramanyam A; Satterwhite O; Taylor JE; Foreyt JP
Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1486-93. PubMed ID: 14634679
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in a randomised placebo-controlled trial of sibutramine in obese patients with type II diabetes.
Kaukua JK; Pekkarinen TA; Rissanen AM
Int J Obes Relat Metab Disord; 2004 Apr; 28(4):600-5. PubMed ID: 14770192
[TBL] [Abstract][Full Text] [Related]
19. Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine.
Hainer V; Kunesova M; Bellisle F; Hill M; Braunerova R; Wagenknecht M
Int J Obes (Lond); 2005 Feb; 29(2):208-16. PubMed ID: 15583700
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
